Ishares Msci Brazil ETF vs Medtronic PLC — how do they compare? Ishares Msci Brazil ETF trades at $35.48, while Medtronic PLC trades at $83.83 (market cap $103.01B). The key difference: Medtronic PLC pays a 3.58% dividend while Ishares Msci Brazil ETF pays none, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| EWZ | MDT | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $41.75 | $105.35 |
52-Week Low | $26.52 | $73.75 |
Market Cap | — | $103.01B |
Enterprise Value | — | $121.75B |
Dividend Yield | — | 3.58% |
Signals from Pluang's Aura AI — not financial advice
EWZ (iShares MSCI Brazil ETF) trades at $35.365, down 1.85% today but maintains a bullish technical outlook with 15 buy signals versus 4 sell signals. The ETF has gained approximately 11% year-to-date, benefiting from Brazil's monetary easing cycle and commodity strength. Recent news highlights Brazil's $9.92 billion Eco Invest auction and export regulation adjustments to meet EU requirements, supporting economic momentum.
The outlook for EWZ remains positive as Brazil's central bank continues rate cuts from historically high levels, creating favorable conditions for equities. Key risks include dependency on commodity prices and potential economic volatility. Analyst sentiment leans bullish with expectations of further upside from monetary policy support and attractive valuations in Brazilian markets.
Medtronic (MDT) trades at $79.30, down 5.11% over 24 hours, with technical indicators showing bearish momentum. Fundamentally, the company reported strong earnings beats for three consecutive quarters and maintains solid profitability with a 13.2% net income margin. Recent news highlights the completion of the Scientia Vascular acquisition and bullish analyst coverage citing undervaluation and growth in cardiovascular and neuroscience segments.
The stock presents a compelling opportunity with a consensus price target of $97.50 representing 23% upside, supported by 58% analyst buy ratings. Key risks include increasing debt-to-asset ratios (31.11% in 2025) and margin pressures from tariffs and foreign exchange. The dividend aristocrat offers a near-decade high yield with consistent dividend growth.
Trailing returns across standard periods
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →